Rare diseases
Investigational molecules
Locations
Back to France315 clinical trials in Metz, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)A Phase III Study of Lenbelintide in Adults with Obesity or Overweight and Weight‑Related Comorbidity Without Type 2 Diabetes
FranceEvaluation of Anifrolumab Subcutaneous Treatment in Immunosuppressant‑Naïve and Biologic‑Naïve Patients with Systemic Lupus Erythematosus
FranceLong-term Safety and Efficacy of Remibrutinib in Adults with Moderate to Severe Hidradenitis Suppurativa
FranceOrelabrutinib in Patients with Primary Progressive Multiple Sclerosis
FranceStudy of BNT327 and a drug combination for patients with untreated metastatic or locally recurrent triple-negative breast cancer
FranceA study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis
FranceLong-term safety study of deucravacitinib compared to ustekinumab in adults with moderate to severe plaque psoriasis
FranceA Study of Ivonescimab Combined with Fluorouracil, Folinic Acid, and Oxaliplatin Compared to Bevacizumab for Patients with Metastatic Colorectal Cancer
FranceStudy of icotrokinra for adults with moderately to severely active Crohn's disease
FranceA Study to Test if Rinvecalinase Alfa is Safe and Works for Treating Acute Ischemic Stroke in Patients with Moderate Stroke Severity
FranceLong-term safety study of oral povorcitinib in patients with hidradenitis suppurativa, prurigo nodularis, or vitiligo who previously participated in clinical trials
FranceStudy of personalized treatment using drug combination therapy for young women with early stage hormone receptor-positive breast cancer based on gene expression testing
FranceThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking research focusing on multiple myeloma treatments, including novel combinations of therapies and maintenance strategies. Studies evaluating new approaches for lymphoma and advanced breast cancer treatments.
Several trials exploring targeted therapies and immunotherapy combinations for better patient outcomes.
Advanced research in non-small cell lung cancer treatment, particularly focusing on elderly patients. Studies examining antibiotic optimization in COPD exacerbations.
Innovative approaches combining immunotherapy with conventional treatments.
Clinical investigations in lupus nephritis and atopic dermatitis, exploring steroid-free treatment options and novel biological therapies.
Focus on reducing steroid dependency while maintaining treatment efficacy.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
